Drugs / rVSV-SUDV

Trials 1

2024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT05909358 Jul 2023 → Sep 2027 expected — Makerere University Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as rVSV-SUDV ClinicalTrials.gov intervention name — accepted as the source's own label NCT05909358 ↗
Modality Vaccine “rVSV-SUDV candidate vaccine” NCT05909358 ↗